Fundz

Appili Therapeutics Announces Update To Funding Agreement With The Lind Partners

PRIVATEDec 22, 2021

Round Type

Funding Round

HalifaxBiotechnologyHealth CareScience And Engineering

Description

Appili Therapeutics Inc. (TSX:APLI) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases, announced today that the Company and Lind Global Fund II, LP, an investment entity managed by The Lind Partners, a New York based institutional fund manager (together "Lind"), have agreed to amend certain terms of the previously announced senior convertible funding agreement (the “Funding Agreement”).

Quick answer

Appili Therapeutics Inc. raised an undisclosed amount in a Funding Round round, dated December 22, 2021. Appili Therapeutics Inc. is based in Halifax, England, United Kingdom.

How much did Appili Therapeutics Inc. raise?
Appili Therapeutics Inc. raised an undisclosed amount in a Funding Round round on December 22, 2021.
What does Appili Therapeutics Inc. do?
Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections.
Where is Appili Therapeutics Inc. based and how big is it?
Appili Therapeutics Inc. is based in Halifax, England, United Kingdom.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Biotechnology around the same time

Companies in the same sectors as Appili Therapeutics Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Dewpoint Therapeutics raised $150M on February 4, 2022.
  • Dewpoint Therapeutics raised $150M (Series C) on February 3, 2022.
  • Septerna raised $100M (Series A) on January 27, 2022.
  • Advanced NanoTherapies raised $9.2M on January 26, 2022.
  • Kyverna Therapeutics raised $85M (Series B) on January 26, 2022.
  • Enliven Therapeutics raised an undisclosed amount (Funding Round) on January 19, 2022.

Who to call at Appili Therapeutics Inc., and when

A new round usually means Appili Therapeutics Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Appili Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Appili Therapeutics Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Appili Therapeutics Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Appili Therapeutics Inc.

Location

21-1344 SUMMER ST.

Halifax, England, United Kingdom

About

Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, Appili’s goal is to strategically develop a pipeline of novel therapies to prevent deaths and improve lives.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Appili Therapeutics Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Appili Therapeutics Inc.'s next move

See what Strategic adds

Appili Therapeutics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.